NASDAQ:ABUS   Arbutus Biopharma Corporation
Because of the convergence we see in the chart and the RSI, and the gray support range that indicates the fall to that range has not been seen, we will probably see that the chart experiences some re-fall. If the pull back up, we will have price growth up to the gray resistance range. And God knows
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.